News

July 26, 2012 — A new study shows promising data for a new method to image the source of atrial fibrillation (AF) and target its ablation to greatly reduce procedure time and substantially improve...

 

June 18, 2012 — Epicardial ablation device maker Contact Inc. announced that new long-term physician data demonstrated promising clinical outcomes for the multidisciplinary...

June 18, 2012 — Endosense announced its TactiCath Quartz force-sensing ablation catheter has been CE mark approved...

June 15, 2012 —Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has...

June 15, 2012 — Cardiosolutions Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Dexterity Steerable Introducer, a next-generation...

The latest trends and newest cardiac rhythm management technology were highlighted during the biggest electrophysiology (EP) meeting in the world, Heart Rhythm Society (HRS) 2012 in May, held in...

May 24, 2012 —Advanced Cardiac Therapeutics Inc., a developer of temperature-sensing cardiac ablation systems, today announced results of several studies related to the company’s Tempasure cardiac...

May 24, 2012 -- nContact Inc., a provider of  epicardial ablation devices, announced that new long-term physician data demonstrated promising clinical outcomes for the multidisciplinary...

A new electromapping technique can better visualize the rotor (similar to the eye of a hurricane) around which atrial fibrillation electrical activity rotates. Using this map, the...

Patients with the heart rhythm disorder atrial fibrillation (AFib) who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving anti-...

May 14, 2012 – Endosense said there has been strong interest and significant advancement in the move toward making contact-force sensing a standard-of-care in ...

The new irrigated ablation catheter combines Biosense Webster’s latest porous tip technology with the accurate visualization of the Carto3 3-D mapping and ablation system. This enhanced technology...

May 9, 2012 — Sound Interventions Inc. announced the successful completion of the company's first-in-human clinical trial to treat resistant hypertension, SOUND-ITV.

ReCor Medical disclosed updated data for the REDUCE First-In-Man clinical study of its CE-marked Paradise (percutaneous renal denervation system) ultrasound platform, which is...

March 16, 2012 — Boston Scientific Corp. announced Health Canada approval of the Blazer open-irrigated catheter, the company's latest radiofrequency ablation (RFA) catheter designed to treat a...

The Heart Rhythm Society (HRS) issued an international consensus statement on indications, techniques and outcomes of catheter and surgical ablation of atrial fibrillation (AF).

February 28, 2012 — nContact Inc. announced a new preclinical study examining a unique minimally invasive percutaneous approach to accessing the heart that may enable electrophysiologists (EPs) to...

February 24, 2012 — CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced the first patient has been enrolled and...

PARADISE

February 20, 2012 — ReCor Medical announced that its Paradise percutaneous ultrasound renal denervation system for achieving rhas received the CE mark. Paradise is designed to treat patients with...

February 15, 2012 — Vessix Vascular Inc., developer of a novel percutaneous radiofrequency (RF) balloon catheter technology, announced that it will make its first detailed public presentation of...